Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) — The “Oral Solid Dosage Forms (OSDF) and Pharma Excipients – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Oral Solid Dosage Forms (OSDF) and Pharma Excipients was valued at USD 1.3 Billion in 2024 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 5.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
How are Regulatory and Industry Trends Shaping the OSDF and Pharma Excipients Market?
The OSDF and pharma excipients market is closely regulated by global health authorities, ensuring that both the active drug and excipients meet stringent safety, efficacy, and quality standards. These regulations are driving manufacturers to invest in high-quality excipients and state-of-the-art manufacturing processes to ensure compliance with good manufacturing practices (GMP).
Additionally, the rise of personalized medicine and the growing demand for patient-centric dosage forms are influencing the market, with a focus on developing tailored excipients and formulations that can accommodate specific patient needs, such as pediatric or geriatric populations. Sustainability is also becoming a key consideration, with companies exploring environmentally friendly excipient alternatives.
The Growth in the OSDF and Pharma Excipients Market Is Driven by Several Factors
The growth in the oral solid dosage forms and pharma excipients market is driven by several factors, including the widespread preference for OSDFs due to their convenience, stability, and cost-effectiveness. Technological advancements in drug formulation and excipient development are enabling the creation of more sophisticated and effective drug delivery systems, including controlled-release and targeted therapies.
Regulatory demands for high-quality, compliant excipients are also pushing innovation in this sector. Additionally, the rise of complex drug compounds, biologics, and personalized medicine is creating new opportunities for specialized excipients. Moreover, the increasing demand for sustainable and patient-centric dosage forms is further driving the development of novel excipient technologies.
Report Scope
The report analyzes the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.
Segments
Segment (Polymers, Alcohols, Minerals, Gelatin, Other Segments).
Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Polymers segment, which is expected to reach $932.4 Million by 2030 with a CAGR of a 6.2%. The Alcohols segment is also set to grow at 4.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $363.4 Million in 2024, and China, forecasted to grow at an impressive 4.8% CAGR to reach $280.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abitec Corporation, Akzo Nobel NV, Archer Daniels Midland Company, Associated British Foods PLC, Avantor Performance Materials LLC and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 46 major companies featured in this Oral Solid Dosage Forms (OSDF) and Pharma Excipients market report include:
- Abitec Corporation
- AkzoNobel NV
- Archer Daniels Midland Company
- Associated British Foods PLC
- Avantor Performance Materials LLC
- BASF SE
- Cabot Corporation
- Cargill, Inc.
- Celanese Corporation
- Croda International PLC
- Dow, Inc.
- DuPont de Nemours, Inc.
- Eastman Chemical Company
- Ferro Corporation
- FMC Corporation
- Huntsman Corporation
- Ingredion, Inc.
- Innophos Holdings, Inc.
- J.M. Huber Corporation
- Kuraray Co., Ltd.
- Medtronic PLC
- Merck KGaA
- Nitta Gelatin, Inc.
- Procter & Gamble Company, The
- Royal Dutch Shell PLC
- The Lubrizol Corporation
Key Attributes
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $1.3 Billion |
| Forecasted Market Value (USD) by 2030 | $1.8 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
- Oral Solid Dosage Forms (OSDF) and Pharma Excipients – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Growing Preference for OSDFs Due to Convenience and Compliance
- Advancements in Excipients for Improved Drug Delivery and Stability
- Rising Demand for Sustained and Controlled-Release Formulations
- Increased Focus on Personalized Medicine and Patient-Centric Therapies
- Expanding Use of High-Functionality Excipients for Complex Formulations
- Growth of the Generic Drugs Market Driving Demand for Cost-Effective Excipients
- Innovations in Excipients for Biopharmaceuticals and Targeted Therapies
- Increasing Investment in R&D for Novel Drug Delivery Systems
- Demand for Excipients with Enhanced Solubility for Poorly Water-Soluble Drugs
For more information about this report visit https://www.researchandmarkets.com/r/wunoue
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
